51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01553981 (ClinicalTrials.gov)	March 2012	11/3/2012	A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma	A Double Blind Randomized Control Trial of Tadalafil in Interstitial Lung Disease of Scleroderma	Lung Diseases, Interstitial	Drug: Tadalafil;Drug: Placebo	Sanjay Gandhi Postgraduate Institute of Medical Sciences	NULL	Completed	18 Years	70 Years	Both	40	Phase 3	India
2	NCT01042158 (ClinicalTrials.gov)	January 2010	4/1/2010	A Clinical Trial of Ambrisentan and Tadalafilin Pulmonary Arterial Hypertension Associated With Syst ...	A Clinical Trial of Ambrisentan and Tadalafilin Pulmonary Arterial Hypertension Associated With Syst ...	Pulmonary Arterial Hypertension;Systemic Sclerosis;Scleroderma Spectrum of Diseases;Connective Tissu ...	Drug: tadalafil and ambrisentan upfront combination therapy	Johns Hopkins University	National Institutes of Health (NIH);National Heart, Lung, and Blood Institute (NHLBI);Eli Lilly and ...	Completed	18 Years	N/A	All	25	Phase 4	United States
3	NCT01117298 (ClinicalTrials.gov)	November 2009	3/5/2010	A Randomized Control Trial to Assess the Efficacy of Tadalafilin Raynaud's Phenomenon in Scleroderma ...	A Randomized Control Trial to Assess the Efficacy of Tadalafilin Raynaud's Phenomenon in Scleroderma ...	Raynaud's Phenomenon;Digital Ulcers;Scleroderma	Drug: Tadalafil;Drug: Placebo	Sanjay Gandhi Postgraduate Institute of Medical Sciences	Institute of Postgraduate Medical Education and Research;Postgraduate Institute of Medical Education ...	Completed	18 Years	65 Years	Both	66	Phase 3	India
4	NCT00626665 (ClinicalTrials.gov)	December 2007	21/2/2008	Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma	Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma	Raynaud Disease	Drug: Tadalafil	Sanjay Gandhi Postgraduate Institute of Medical Sciences	NULL	Completed	18 Years	70 Years	Both	25	Phase 3	NULL

First Previous1Next Last